col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


39 Results       Page 1

 [1] 
Informa UK (Taylor & Francis): Leukemia & Lymphoma
  original article Date Title Authors   All Authors
1 [GO] 2022―May―14 Patients with plasma cell disorders undergoing autologous stem cell transplant retain their humoral response to COVID-19 vaccination but falling titers emphasize the importance of re-vaccination Lara Howells, Wei Yee Chan, Emilie Sanchez, Jacqueline Horder, Fiona Newrick, Jotham Marfil, et al. (+13)
2 [GO] 2022―Apr―28 Severe presentations and high mortality from SARS-CoV-2 in patients undergoing chimeric antigen receptor (CAR-T) therapy: a UK NCCP analysis Kathleen P. L. Cheok, Amy A. Kirkwood, Tobias Menne, Eleni Tholouli, Sridhar Chaganti, Amrith Mathew, et al. (+12)
3 [GO] 2022―Mar―27 How COVID-19 pandemic changed our attitude to venetoclax-based treatment in chronic lymphocytic leukemia Marina Deodato, Anna Maria Frustaci, Paolo Sportoletti, Luca Laurenti, Roberta Murru, Andrea Visentin, et al. (+19)
4 [GO] 2022―Feb―27 COVID-19 booster vaccines generate seroconversion in subset of patients with lymphoma/CLL: single institution experience Neha Mehta-Shah, Nancy L. Bartlett, Brad Kahl, Marcus P. Watkins, Amalia Dubois, Gabby Schmelzle, et al. (+4)
5 [GO] 2022―Feb―14 COVID-19 in patients with chronic lymphocytic leukemia: a Moscow observational study Оlga L. Kochneva, Maria Kislova, Evgenya I. Zhelnova, Andrei A. Petrenko, Elena A. Baryakh, Konstantin V. Yatskov, et al. (+8)
6 [GO] 2022―Feb―02 Anti CD20-based immunochemotherapy abolishes antibody response to Covid-19 mRNA vaccine in lymphoma patients vaccinated during active first line treatment Silvia Bellesi, Michela Sali, Elena Maiolo, Maria del Carmen Pereyra Boza, Eleonora Alma, Ivana Palucci, et al. (+7)
7 [GO] 2022―Jan―24 Long-term persistence of natural anti-SARS-CoV-2 antibodies and mild impact of SARS-CoV-2 infection in CML patients: results from a seroprevalence study Simone Claudiani, Eleanor L. Parker, Dragana Milojkovic, Carolina Rosadas, Afzal Khan, Ksenia Katsanovskaja, et al. (+6)
8 [GO] 2022―Jan―06 Telehealth access among hematology patients during the COVID-19 pandemic in Australia: a cross-sectional survey Nienke Zomerdijk, Michelle I Jongenelis, Jane Turner, Kathryn Huntley, Andrew Smith, Camille E. Short
9 [GO] 2021―Oct―28 Cellular response to COVID-19 vaccines in hematologic malignancies patients: a new hope for non-responders? Imane Saad Albichr, Julien De Greef, Eric Van Den Neste, Xavier Poiré, Violaine Havelange, Marie-Christiane Vekemans, et al. (+5)
10 [GO] 2021―Oct―21 Spanish Society of Hematology and Hemotherapy expert consensus opinion for SARS-CoV-2 vaccination in onco-hematological patients José Luis Piñana, Lourdes Vázquez, Rodrigo Martino, Rafael de la Cámara, Anna Sureda, Rebeca Rodríguez-Veiga, et al. (+25)
11 [GO] 2021―Oct―20 COVID-19 and seasonal influenza: a comparative analysis in patients with hematological malignancies Franziska Modemann, Christian Niederwieser, Katja Weisel, Carsten Bokemeyer, Walter Fiedler, Susanne Ghandili
12 [GO] 2021―Sep―15 Worsening of COVID-19 after chemotherapy in patients considered to have recovered from a SARS-CoV-2 infection Arthur Poncelet, Gil Verschelden, Martin Colard, Marc Hildebrand, Maya Hites, Nicolas Yin, et al. (+3)
13 [GO] 2021―Sep―02 Improvement in mortality of hospitalized patients with hematological malignancies in the 2nd wave of COVID-19 in the UK: experience of a large London NHS trust Richard Hinton, George Nesr, Catherine Garnett, David Foldes, Joel James Robert McCay, Rachael Medland, et al. (+6)
14 [GO] 2021―Aug―18 COVID-19 among patients with hematological malignancies: a national Israeli retrospective analysis with special emphasis on treatment and outcome Ilana Levy, Avital Lavi, Eran Zimran, Sigal Grisariu, Shlomzion Aumann, Gilad Itchaki, et al. (+26)
15 [GO] 2021―Aug―13 Acute leukemia and SARS-CoV-2 infection: clinical characteristics and risk factors for mortality Mirjana Mitrovic, Nikola Pantic, Nikica Sabljic, Miodrag Vucic, Zoran Bukumiric, Marijana Virijevic, et al. (+5)
16 [GO] 2021―Jul―27 Between a rock and a hard place: COVID-19 vaccination and patients on rituximab therapy Benjamin W. Teh, Constantine S. Tam
17 [GO] 2021―Jul―22 Characteristics, clinical outcomes, and risk factors of SARS-COV-2 infection in adult acute myeloid leukemia patients: experience of the PETHEMA group Tomás Palanques-Pastor, Juan Eduardo Megías-Vericat, Pilar Martínez, José Luis López Lorenzo, Javier Cornago Navascués, Gabriela Rodriguez Macias, et al. (+37)
18 [GO] 2021―Jul―15 Systematic screening for SARS-CoV-2 in patients with hematological malignancies on active anticancer treatment in the outpatient setting Marzia Varettoni, Silvia Mangiacavalli, Sara Rattotti, Claudio Salvatore Cartia, Chiara Cavalloni, Franca Rossetti, et al. (+13)
19 [GO] 2021―Jul―13 COVID-19 in chronic myeloid leukemia patients in Latin America Katia B. Pagnano, Evelyn Herrera Peralta, Juan Ramon Navarro, Lourdes del Rosario David Salas, Nancy Delgado, Beatriz Moiraghi, et al. (+23)
20 [GO] 2021―Jun―28 Neutropenia in adult acute myeloid leukemia patients represents a powerful risk factor for COVID-19 related mortality Maximilian Stahl, Varun Narendra, Justin Jee, Andriy Derkach, Molly Maloy, Mark B. Geyer, et al. (+6)
21 [GO] 2021―Jun―24 Impact of COVID-19 on peripheral blood stem cell mobilization for myeloma patients Marquita Camilleri, Thomas McGrath, William Wilson, Stuart J. Ings, Jacqueline Horder, Fiona Newrick, et al. (+6)
22 [GO] 2021―Jun―21 COVID-19 vaccination in patients on rituximab: a survey of lymphoma physicians at NCI designated cancer centers Marcus Messmer, Nina Wagner-Johnston
23 [GO] 2021―May―11 Recurrence of primary cutaneous CD30-positive lymphoproliferative disorder following COVID-19 vaccination Caitlin M. Brumfiel, Meera H. Patel, David J. DiCaudo, Allison C. Rosenthal, Mark R. Pittelkow, Aaron R. Mangold
24 [GO] 2021―Mar―17 Convalescent hyperimmune plasma in patients with hematologic malignancies and severe COVID-19 infections Alain Mina, Sara Small, Leonidas C. Platanias
25 [GO] 2021―Feb―28 Lessons learned for successful treatment of AML in the second wave of COVID-19 outbreak A. Ramírez-López, P. Lázaro del Campo, K. Humala, B. De la Cruz Benito, I. Sánchez-Vadillo, A. López de la Guía, et al. (+3)
26 [GO] 2021―Feb―23 Severe IgA-mediated autoimmune hemolytic anemia triggered by SARS-CoV-2 infection Aude Mausoleo, Soledad Henriquez, Cécile Goujard, Anne-Marie Roque-Afonso, Nicolas Noel, Olivier Lambotte
27 [GO] 2021―Jan―29 Haematological malignancy and nosocomial transmission are associated with an increased risk of death from COVID-19: results of a multi-center UK cohort Talvinder Bhogal, Umair T. Khan, Rebecca Lee, Alexander Stockdale, Christian Hesford, Vaishnav Potti-Dhananjaya, et al. (+17)
28 [GO] 2021―Jan―22 Anemia and red blood cell abnormalities in COVID-19 Philip Murphy, Siobhan Glavey, John Quinn
29 [GO] 2021―Jan―19 Convalescent hyperimmune plasma for chemo-immunotherapy induced immunodeficiency in COVID-19 patients with hematological malignancies Silvia Ferrari, Chiara Caprioli, Alessandra Weber, Alessandro Rambaldi, Federico Lussana
30 [GO] 2021―Jan―10 Severe COVID-19 infection in a patient with paroxysmal nocturnal hemoglobinuria on eculizumab therapy Alexis Genthon, Thibault Chiarabini, Pierre Baylac, Nadia Valin, Tomas Urbina, Jérome Pacanowski, et al. (+7)
31 [GO] 2020―Dec―26 Evolving management strategies for lymphomas during the COVID-19 pandemic Noemie Lang, John Kuruvilla
32 [GO] 2020―Dec―03 COVID-19 in patients with multiple myeloma: a cross-sectional survey from the most severely affected region in China Chunyan Sun, Junying Li, Hang Xiang, Chunrui Li, Anfang Shang, Wei Chang, et al. (+13)
33 [GO] 2020―Nov―10 Outcome of hospitalized patients with hematological malignancies and COVID-19 infection in a large urban healthcare trust in the United Kingdom Catherine Garnett, David Foldes, Chris Bailey, George Nesr, Tracy Hui, Richard Hinton, et al. (+10)
34 [GO] 2020―Sep―09 Efficacy and safety of ruxolitinib for Covid-19 related acute respiratory distress syndrome in a patient with blastic plasmacytoid dendritic cell neoplasm (leukemic variant) Vincenzo Sammartano, Adele Santoni, Bruno Frediani, Anna Sicuranza, Cencini Emanuele, Federico Franchi, et al. (+2)
35 [GO] 2020―Aug―25 Clinical characteristics, therapeutic management, and prognostic factors of adult COVID-19 inpatients with hematological malignancies Yaogong Wu, Wenlan Chen, Wenjing Li, Miaomiao Zhao, Qiuzhe Wei, Xiaoping Zhang, et al. (+3)
36 [GO] 2020―Jul―23 The management of chronic lymphoproliferative disorders at the time of SARS-Covid2 pandemic: weathering the storm Anna Maria Frustaci, Giulia Zamprogna, Marina Deodato, Roberto Cairoli, Marco Montillo, Alessandra Tedeschi
37 [GO] 2020―Jul―09 Hematological manifestations of COVID-19 Alain Mina, Koen van Besien, Leonidas C. Platanias
38 [GO] 2020―Jul―02 Continuous high-dose ivermectin appears to be safe in patients with acute myelogenous leukemia and could inform clinical repurposing for COVID-19 infection Claudio Galvao de Castro Jr., Lauro Jose Gregianin, Jan A. Burger
39 [GO] 2020―Jun―17 SARS-CoV-2 in multiple myeloma: initial observation and management Elisabet E. Manasanch, Victor Mulanovich, Joanna-Grace Manzano, Maria Susan Gaeta, Melody Becnel, Gregory P. Kaufman, et al. (+9)
 [1] 

39 Results       Page 1



[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.018 sec